Provided by Tiger Fintech (Singapore) Pte. Ltd.

Korro Bio, Inc.

13.90
+0.44003.27%
Post-market: 13.900.00000.00%18:15 EDT
Volume:84.63K
Turnover:1.15M
Market Cap:130.51M
PE:-1.48
High:13.94
Open:13.41
Low:13.06
Close:13.46
Loading ...

Piper Sandler Reaffirms Their Buy Rating on Korro Bio (KRRO)

TIPRANKS
·
13 Nov 2024

RBC Capital Sticks to Their Buy Rating for Korro Bio (KRRO)

TIPRANKS
·
13 Nov 2024

Korro Bio Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

Korro Bio Q3 EPS $(2.26) Beats $(2.61) Estimate

Benzinga
·
13 Nov 2024

Korro Bio Inc Qtrly Shr Loss $2.26

THOMSON REUTERS
·
13 Nov 2024

Korro: Cash Runway Into Second Half of 2026 Expected to Fund Krro-110 Through Completion of Phase 1/2 Clinical Study

THOMSON REUTERS
·
13 Nov 2024

Korro Bio Inc expected to post a loss of $2.61 a share - Earnings Preview

Reuters
·
07 Nov 2024

BRIEF-Korro Announces Regulatory Filing For Initiation Of KRRO-110 First-In-Human Study

Reuters
·
04 Nov 2024

Korro Bio - Interim Readout Expected in H2 2025 & Completion of Phase 1/2 Study Anticipated in 2026

THOMSON REUTERS
·
04 Nov 2024

Korro Bio Inc - First Participant Dosing Anticipated in Q1 of 2025

THOMSON REUTERS
·
04 Nov 2024

Korro Announces Regulatory Filing for Initiation of Krro-110 First-in-Human Study and Formation of Clinical Advisory Board

THOMSON REUTERS
·
04 Nov 2024

Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board

GlobeNewswire
·
04 Nov 2024

Korro Bio Inc expected to post a loss of $2.61 a share - Earnings Preview

Reuters
·
30 Oct 2024

Analysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Collegium Pharmaceutical (COLL) and Korro Bio (KRRO)

TIPRANKS
·
24 Oct 2024

Korro Bio Is Maintained at Outperform by RBC Capital

Dow Jones
·
21 Oct 2024

Korro Bio Initiated at Strong Buy by Raymond James

Dow Jones
·
21 Oct 2024

RBC Raises Price Target on Korro Bio to $105 From $95, Keeps Outperform, Speculative Risk

MT Newswires Live
·
21 Oct 2024

Korro Bio initiated with a Strong Buy at Raymond James

TIPRANKS
·
21 Oct 2024

Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Korro Bio (KRRO) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
21 Oct 2024

Korro Bio Inc : RBC Raises Target Price to $105 From $95

THOMSON REUTERS
·
21 Oct 2024